Reported 17,700,000 shares, up 5,000,000 (39.4%) from the prior quarter.
Reported value 27.7%; share count 39.4% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 10870000 |
| 2022-03-31 | 14624000 |
| 2022-06-30 | 18674000 |
| 2022-09-30 | 22913000 |
| 2022-12-31 | 24473438 |
| 2023-03-31 | 32589833 |
| 2023-06-30 | 40617120 |
| 2023-09-30 | 39922620 |
| 2023-12-31 | 50204252 |
| 2024-03-31 | 51538438 |
| 2024-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2024 | Unchanged | 0 | 0 (0.0%) | 0 | $0 | 2024-08-14 | |
| Q1 2024 | Unchanged | 0 | 0 (0.0%) | 0.19% | $51,538,438 | 2024-05-01 | |
| Q4 2023 | Reduced | 0 | -40,200,000 (-100.0%) | 0.15% | $50,204,252 | 2024-02-12 | |
| Q3 2023 | Unchanged | 40,200,000 | 0 (0.0%) | 0.18% | $39,922,620 | 2023-11-13 | |
| Q2 2023 | Added | 40,200,000 | +8,000,000 (24.8%) | 0.2% | $40,617,120 | 2023-08-10 | |
| Q1 2023 | Added | 32,200,000 | +9,500,000 (41.9%) | 0.16% | $32,589,833 | 2023-05-09 | |
| Q4 2022 | Unchanged | 22,700,000 | 0 (0.0%) | 0.18% | $24,473,438 | 2023-02-10 | |
| Q3 2022 | Added | 22,700,000 | +5,000,000 (28.2%) | 0.14% | $22,913,000 | 2022-11-10 | |
| Q2 2022 | Added | 17,700,000 | +5,000,000 (39.4%) | 0.09% | $18,674,000 | 2022-08-15 | |
| Q1 2022 | Added | 12,700,000 | +3,000,000 (30.9%) | 0.04% | $14,624,000 | 2022-05-13 | |
| Q4 2021 | Unchanged | 9,700,000 | 0 (0.0%) | 0.02% | $10,870,000 | 2022-02-11 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
24 managers reported IRONWOOD PHARMACEUTICALS IN for Q2 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | Added | 93,100,000 | +3,000,000 | 0.03% | $98,152,000 | 8 qtrs |
| WOLVERINE ASSET MANAGEMENT LLC | Unchanged | 0 | 0 | 0.29% | $29,301,000 | 8 qtrs |
| CAPSTONE INVESTMENT ADVISORS LLC This report | Added | 17,700,000 | +5,000,000 | 0.09% | $18,674,000 | 8 qtrs |
| TENOR CAPITAL MANAGEMENT Co L P | Added | 14,416,000 | +4,000,000 | 0.34% | $15,218,000 | 8 qtrs |
| SHENKMAN CAPITAL MANAGEMENT INC | Added | 11,052,000 | +7,089,000 | 0.69% | $11,459,000 | 8 qtrs |
| Jefferies Group LLC | Added | 10,096,000 | +3,169,000 | 0.09% | $10,674,524 | 8 qtrs |
| Calamos Advisors LLC | Unchanged | 7,500 | 0 | 0.03% | $7,910,000 | 8 qtrs |
| AQR Arbitrage LLC | Unchanged | 5,200,000 | 0 | 0.12% | $5,486,000 | 8 qtrs |
| Daiwa Securities Group Inc | New | 5,000,000 | +5,000,000 | 0.04% | $5,261,000 | 3 qtrs |
| ABSOLUTE INVESTMENT ADVISERS LLC | New | 3,500,000 | +3,500,000 | 0.73% | $3,675,000 | 1 qtr |
Filing details and methodology As reported
- Report period
- June 30, 2022
- Filed
- August 15, 2022
- Filing type
- 13F-HR
- Position type
- NOTE 0.750% 6/1
Voting authority reported
- Sole
- 17,700,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.